Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Tom Gordon who wrote (6699)	2/7/2001 7:26:17 PM
From: john.d	Read Replies (1) \| Respond to of 14101

Tom Gordon said: "FDA's endorsement of Pennsaid as the safe remedy will leave Vioxx and Celebrex in the dust. We will help resolve there bickering...... Look for them to gang up on our little co.!....... Do you get the feeling Merck and Pfizer are running a little scared and are looking over there shoulder." Tom, if they see a real threat from Dimethaid, I wonder if one or both (that would be nice for the share price) might decide to take a run(buyout) at Dimethaid. If they did, what's to stop them? With over 42 million shares out and growing, and with less than 5-10 million (guess)in friendly hands that may be a real threat?? If so, we may get taken out a price a lot less than some of us are expecting over the long term. Who knows, Rebecca may be taking a bit of a low profile so not as to wake the sleeping giant......until she's in a stronger position, with respect to share price. This news sure makes this an even more interesting play. John